In transgenic mouse models of amyloidosis, when the shared p40 subunit is removed genetically or blocked pharmacologically with specific antibodies, both IL-12 and IL-23 signaling were inhibited causing a decrease in AD pathology (Vom Berg et al. 2012; Eede et al. 2020). This evidence concerns the gene IL9 and Alzheimer disease.